Triethylamine → (S)-6-Amino-2-[3-((13S,16R)-13-isopropyl-15-oxo-2,11-dioxa-14-azabicyclo[16.2.2]docosa-1(21),18(22),19-trien-16-yl)ureido]hexanoic acid

HRID 2274541Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2274541
[NH2:1][C@@H:2]1[CH2:21][C:20]2=[CH:22][CH:23]=[C:17]([CH:18]=[CH:19]2)[O:16][CH2:15][CH2:14][CH2:13][CH2:12][CH2:11][CH2:10][CH2:9][CH2:8][O:7][CH2:6][C@H:5]([CH:24]([CH3:26])[CH3:25])[NH:4][C:3]1=[O:27].[C:28](N1C=CN=C1)(N1C=CN=C1)=[O:29].C(N(CC)CC)C.Cl.[NH2:48][C@@H:49]([CH2:57][CH2:58][CH2:59][CH2:60][NH:61]C(OC(C)(C)C)=O)[C:50]([O:52]C(C)(C)C)=[O:51]>CN(C=O)C>[NH2:61][CH2:60][CH2:59][CH2:58][CH2:57][C@H:49]([NH:48][C:28]([NH:1][C@@H:2]1[CH2:21][C:20]2=[CH:19][CH:18]=[C:17]([CH:23]=[CH:22]2)[O:16][CH2:15][CH2:14][CH2:13][CH2:12][CH2:11][CH2:10][CH2:9][CH2:8][O:7][CH2:6][C@H:5]([CH:24]([CH3:25])[CH3:26])[NH:4][C:3]1=[O:27])=[O:29])[C:50]([OH:52])=[O:51]

Komponenten

6

Edukt 4

HCID 8471TriethylamineHCID 682631,1'-CarbonyldiimidazoleHCID 13819885Ne-Boc-L-lysine tert-butyl ester hydrochlorideHCID 67028556(13S,16R)-16-Amino-13-isopropyl-2,11-dioxa-14-azabicyclo[16.2.2]docosa-1(21),18(22),19-trien-15-one

Produkt 1

HCID 44544518(S)-6-Amino-2-[3-((13S,16R)-13-isopropyl-15-oxo-2,11-dioxa-14-azabicyclo[16.2.2]docosa-1(21),18(22),19-trien-16-yl)ureido]hexanoic acidAusbeute 59,1 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6228DimethylformamideLösungsmittel

Versuchsvorschrift

A solution of 0.18 g (0.37 mmol) of (13S,16R)-16-amino-13-isopropyl-2,11-dioxa-14-azabicyclo[16.2.2]docosa-1(21),18(22),19-trien-15-one in 3.8 ml of DMF was added to 60 mg (0.37 mmol) of 1,1′-carbonyldiimidazole and, after addition of 0.2 ml (0.15 g, 1.47 mmol) of triethylamine, stirred under argon. After 10 min, 124 mg (0.37 mmol) of tert-butyl (S)-2-amino-6-tert-butoxycarbonylaminohexanoate hydrochloride were added, and the mixture was stirred for 3 h. It was concentrated and partitioned between water and ethyl acetate, and the organic phase was dried over sodium sulfate, filtered and concentrated. The residue was purified by preparative HPLC. The required fractions were combined and concentrated. The residue was taken up in 20 ml of dichloromethane/TFA (1:1, v/v) and left to stand for 2 h. The mixture was concentrated, dissolved in 1N hydrochloric acid with a little acetonitrile and freeze dried. An amorphous solid (0.12 g) was obtained as hydrochloride.

Aufarbeitung

  1. stirringthe mixture was stirred for 3 h
  2. concentrationIt was concentrated
  3. custompartitioned between water and ethyl acetate
  4. dry with materialthe organic phase was dried over sodium sulfate
  5. filtrationfiltered
  6. concentrationconcentrated
  7. customThe residue was purified by preparative HPLC
  8. concentrationconcentrated
  9. waitv/v) and left
  10. waitto stand for 2 h
  11. concentrationThe mixture was concentrated
  12. dissolutiondissolved in 1N hydrochloric acid with a little acetonitrile and freeze
  13. customdried

Quellen und Nachweise

ORD-Eintrag
ord-6c91545fe87946adae03eb850bafc2b8
Quelldatensatz
uspto-grants-2015_09
Patentnummer
US09126955B2

Notizen zur Reaktion

Wird geladen…